Analyzing patient data sets from TCGA reveals frequent loss of the CTCF gene in breast and prostate cancer patients, correlating with hypermethylation of CpG islands and hypomethylation of other parts of the genome. This evidence concerns the gene CTCF and Familial prostate cancer.